Multiomics Identification of Radioresistance‐Associated Biomarkers and Prognostic Model Construction in Rectal Cancer
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/2759900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 22.05.2026. Verfasst von Zongxueni Deng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China, sdfyy.cn. Hauptthemen laut MEDLINE: Rectal Neoplasms, Biomarkers, Tumor, Radiation Tolerance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Radiotherapy remains a cornerstone in the local management of rectal cancer (RC); however, resistance to radiation significantly compromises therapeutic efficacy and adversely affects patient prognosis. Identification of biomarkers associated with radioresistance and the development of a prognostic model based on radiotherapy‐related genes in RC remain critical for enhancing treatment outcomes.
Methods
Data related to RC were obtained from public repositories, including bulk RNA‐seq data from 993 patients across four Gene Expression Omnibus (GEO) and one The Cancer Genome Atlas (TCGA) cohort, as well as single‐cell RNA‐seq data from six samples. A prognostic model was developed using differential expression analysis, functional enrichment analysis, and least absolute shrinkage and selection operator regression analysis. Associations between risk score and prognosis were assessed through gene set variation analysis, gene set enrichment analysis, and construction of a nomogram to identify potential therapeutic targets for RC.
Results
Prognosis‐related genes were determined through analysis of clinical data from patients with RC in the GEO and TCGA datasets, leading to the development of a risk score model. The risk score demonstrated significant associations with immune cell infiltration, chemotherapy drug sensitivity, and multiple signaling pathways. Protein expression levels of the key genes in patients with RC were verified using the Human Protein Atlas database. Furthermore, immunohistochemical evaluation in animal models provided additional validation.
Conclusion
Molecular characteristics and mechanisms underlying radiotherapy response in RC were clarified through multiomics analysis. Five key genes were identified as potentially related to radiotherapy sensitivity in RC. These prognostic genes may serve as novel biomarkers and potential targets for diagnosis, prognostic evaluation, and clinical management of RC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China, sdfyy.cn.
ORCID-Profile: Zongxueni Deng, Zhenxin Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Deng, Z., Lu, C., & Wang, Z. (2026). Multiomics Identification of Radioresistance‐Associated Biomarkers and Prognostic Model Construction in Rectal Cancer. Human Mutation, 2026(1). https://doi.org/10.1155/humu/2759900
Vancouver
Deng Z, Lu C, Wang Z. Multiomics Identification of Radioresistance‐Associated Biomarkers and Prognostic Model Construction in Rectal Cancer. Human Mutation. 2026;2026(1). doi:10.1155/humu/2759900
BibTeX
@article{Deng2026,
author = {Deng, Zongxueni and Lu, Caiyan and Wang, Zhenxin},
title = {Multiomics Identification of Radioresistance‐Associated Biomarkers and Prognostic Model Construction in Rectal Cancer},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/2759900}
}
EUVIMED